Answers are grounded in this paper and cite their sources.
BACKGROUND Patient journey mapping is a visual representation that illustrates the various touchpoints and interactions a patient has with a healthcare system over time. Patient-centered care (PCC) has been valued in diabetes mellitus (DM) patients, where current digital technology has shown potential to optimize medication management. OBJECTIVE This qualitative study was performed to develop a journey map to ascertain DM patients’ needs for PCC and digital health technology at touchpoints where barriers exist for medication adherence. METHODS The study consisted of four phases: 1) in-depth interviews were first conducted with 12 diabetes mellitus (DM) patients, followed by 2) a systematic review of systematic reviews to identify digital health technologies, which 3) were synthesized with PCC opportunities. Lastly, 4) a patient journey was mapped to highlight touchpoints requiring PCC intervention within the context of digital health. The study unravels the intricate journey from diagnosis to ongoing medication for long-term use. Personas were used to independently explain how patients either adhere well to or poorly follow their regimen. The touchpoints were tailored where digital health technology enables opportunities for PCC in medication management. RESULTS Findings from the qualitative analysis shed light on personalized user experiences, accessibility challenges, and motivational dynamics affecting adherence. A review of 11 recent systematic reviews synthesized digital health technologies for medication adherence, identifying five key technologies that support PCC through enhanced symptom assessment, shared decision-making, and support optimized self-management, and improved communication with peers and providers. Three phases in the patient journey have been identified: diagnosis, medication start, and ongoing medication. CONCLUSIONS This study contributes qualitative insights to the realm of PCC, shifting away from a clinic-based fragmented approach towards a seamless experience incorporating digital health interventions in the medication journey. Digital technologies would better support patients to be fully informed about their illness and treatment, amplifying engagement in care activities and planning with good medication adherence.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: